TPD & Induced Proximity Summit Leaderboard
  • Thursday, July 30, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

Oligonucleotides Analytical Development & CMC Summit Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Pharma Journalist
  • Page 760

Author

Pharma Journalist 8969 posts 0 comments

FDA approves Janssen’s DARZALEX (daratumumab) to treat Multiple Myeloma

May 8, 2018
The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the U.S. Food and Drug Administration (FDA) has approved DARZALEX (daratumumab) in combination with VELCADE …
Read More...

Lannett Acquires Portfolio Of Generic Products From Endo International

May 8, 2018
Lannett Company announced that it has acquired 23 approved and one pending drug product applications from a subsidiary of Endo International plc for an upfront payment plus future…
Read More...

InDex Pharmaceuticals Develops Oral Formulation of Cobitolimod

May 7, 2018
InDex Pharmaceuticals Holding AB (publ) announced that it has developed a novel formulation of its lead drug candidate cobitolimod for oral administration, with targeted delivery to the…
Read More...

FDA approves new uses for two drugs administered together for the treatment of BRAF-positive…

May 7, 2018
The U.S. Food and Drug Administration approved Tafinlar (dabrafenib) and Mekinist (trametinib), administered together, for the treatment of anaplastic thyroid cancer (ATC) that cannot…
Read More...

Schreiner MediPharm Equips Syringes for Pfizer Epoetin Product with Needle-Trap

May 7, 2018
International pharmaceutical corporation Pfizer opted for Schreiner MediPharm’s Needle-Trap needle protection label to equip the syringes for its epoetin biosimilar. This makes it the…
Read More...

Moderna and Merck Expand mRNA Cancer Vaccines Collaboration

May 7, 2018
Moderna Therapeutics and Merck announced an expansion of their 2016 collaboration to develop and commercialize novel personalized messenger RNA (mRNA) cancer vaccines to now include…
Read More...

Lonza to Invest in Portsmouth, NH (USA) Site, Including Mid-Scale Biologics

May 7, 2018
Lonza Pharma & Biotech announced the investment in a new phase of development at their Portsmouth, NH (USA) site. The expansion will include mid-scale mammalian capacity and the…
Read More...

Sylentis Announces the Clinical Results of Tivanisiran for the Treatment of Dry Eye Syndrome

May 4, 2018
Sylentis, Pharmaceutical Company belonging to the PharmaMar Group, has presented results from the clinical studies carried out with tivanisiran for the treatment of dry eye syndrome and…
Read More...

MenoGeniX Awarded NIH Grant to Fund Phase Ib/IIa Clinical Trial

May 4, 2018
MenoGeniX announced that the National Institute on Aging (NIA) of the National Institutes of Health (NIH) has awarded the company a Small Business Innovation Research (SBIR) grant for…
Read More...

Abbott Expands Cardiac Arrhythmias Portfolio with FDA Clearance of Advanced Mapping Catheter

May 4, 2018
Abbott announced U.S. Food and Drug Administration (FDA) clearance of the Advisor HD Grid Mapping Catheter, Sensor Enabled. Advisor HD Grid employs a new design that allows physicians…
Read More...
Prev Next
2nd Obesity & Weight Loss Drug Development Summit Europe
RNA-Based Therapeutics & Vaccines Summit South Korea
RNA-Targeted Drug Discovery & Development Summit
mRNA Process Development & CMC Summit 2026
TPD & Induced Proximity Summit
Measuring Patient Engagement Summit Europe
Oligonucleotides Analytical Development & CMC Summit
11th CAR-TCR Summit
COPD Drug Development Summit
Neuropsychiatric Drug Development Summit
Lab Ops & Facility Management for Biopharma West Summit
10th IPF Summit
Raw Materials for Cell & Gene Therapy Summit
Cell & Gene Therapy Summit South Korea
10th Dermatology Drug Development Summit
9th Lab Asset & Facility Management Summit
TRP Supply Chain & Manufacturing Summit
Covalent Drug Discovery & Development Summit
7th Genome Editing Therapeutics Summit
16th World Clinical Biomarkers & Companion Diagnostics Summit
Lipid Nanoparticles Development Summit Europe
iPSC Drug Development Summit
17th World ADC San Diego
Oligonucleotides for CNS Summit
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • From Innovation to Acquisition: CrossBridge Bio’s ADC Journey
  • COPD Foundations Joins the COPD Drug Development Summit
  • argenx to Acquire Forte Biosciences in $2.2 Billion Deal
  • BioMarin, n-Lorem Join Forces on ReNU Syndrome Therapy
  • Pfizer, Eisai Partner to Co-Promote Nurtec in Japan

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

From Innovation to Acquisition: CrossBridge Bio’s ADC…

COPD Foundations Joins the COPD Drug Development Summit

Advancing Respiratory Medicine Following ATS – What Now?

World ADC San Diego Unveils Preliminary Agenda for 17th…

Regeneron Goes All In on Radiopharma with $2.1B Telix Deal…

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.